Profiel
Judy Chiao worked as VP-Oncology Clinical Research & Development at Aton Pharma, Inc. from 2002 to 2004.
She then worked as VP-Clinical Development & Regulatory Affairs at Cyclacel Pharmaceuticals, Inc. from 2004 to 2021.
Chiao received her undergraduate degree from The Trustees of Columbia University in The City of New York and her doctorate degree from Harvard Medical School.
Eerdere bekende functies van Judy Chiao
| Bedrijven | Functie | Einde |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 05-03-2021 |
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Corporate Officer/Principal | 01-12-2004 |
Opleiding van Judy Chiao
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Health Technology |
